Representative before the EPO

Employment test 1 - 10 employees
Company dna ellens and van essen
operating since 2011
Headquarter in Wageningen
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

We have observed 4 EP applications Peter M. Breepoel has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11769873

SINGLE UNIT ION EXCHANGE CHROMATOGRAPHY ANTIBODY PURIFICATION

IPC classification:
B01D 15/36, C07K 1/18, C07K 16/06
Applicant:
DSM IP Assets B.V.
Agent:
Peter M. Breepoel, DSM Intellectual Property
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13169694

Improved process for the culturing of cells

IPC classification:
C12P 21/00, C12M 3/06, C12M 1/12, C12N 5/073, C12N 5/071
Applicant:
DSM IP Assets B.V.
Agent:
Frans Richard Van den Berg, DPx Fine Chemicals Austria GmbH & Co KG
Agent:
Peter M. Breepoel, DSM Intellectual Property
Status:
PATENT GRANTED
EP13169685

Improved process for the culturing of cells

IPC classification:
C12N 5/073, C07K 1/34, C07K 1/22, C07K 1/18, C07K 16/00, B01D 69/08, B01D 15/26, C12N 5/071, C12P 21/00, C12M 3/06, C12M 1/12
Applicant:
DSM IP Assets B.V.
Agent:
Frans Richard Van den Berg, DPx Fine Chemicals Austria GmbH & Co KG
Agent:
Peter M. Breepoel, DSM Intellectual Property
Status:
PATENT GRANTED
EP13169693

Improved process for the culturing of cells

IPC classification:
C12N 5/073, C07K 1/34, C07K 1/22, C07K 1/18, C07K 16/00, B01D 69/08, B01D 15/26, C12N 5/071, C12P 21/00, C12M 3/06, C12M 1/12
Applicant:
DSM IP Assets B.V.
Agent:
Frans Richard Van den Berg, DPx Fine Chemicals Austria GmbH & Co KG
Agent:
Peter M. Breepoel, DSM Intellectual Property
Status:
The patent has been granted

Please Sign in to use this feature